Skip to content

A Observational Study on Prognosis and Prognostic Factors of Inpatients with Hematological disease ascribed to COVID-19 Infection

A Observational Study on Prognosis and Prognostic Factors of Inpatients with Hematological disease ascribed to COVID-19 Infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068112
Enrollment
Unknown
Registered
2023-02-07
Start date
2023-02-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological disease complicated with COVID-19 infection

Interventions

Hematology group:non
non-hematology group:non

Sponsors

Zhejiang Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of the diagnosis and treatment scheme for novel coronavirus infection (Tenth Edition on trial); (2) Age = 12 years old; (3) The inpatients admitted to the Hematology Department of Zhejiang Provincial Hospital of Traditional Chinese Medicine due to COVID-19 infection this time include patients with blood diseases and non blood diseases.

Exclusion criteria

Exclusion criteria: (1) Patients with serious primary diseases and psychosis of other systems; (2) Those who are participating in other clinical trials; (3) Pregnant or pregnant women, lactating women; (4) The researcher believes that it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
immune globulin;lymphocyte subsets;cytokines;routine blood test;efficacy;

Secondary

MeasureTime frame
Pneumonia scale;

Countries

China

Contacts

Public ContactWu Dijiong

Zhejiang Provincial Hospital of Traditional Chinese Medicine

wdj850@163.com+86571-86620325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026